Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1303

Dec 26, 2020

China Floats Covid-19 Theories That Point to Foreign Origins, Frozen Food

Posted by in categories: biotech/medical, food, government

HONG KONG—China is aggressively advancing alternative theories about the source of the coronavirus that causes Covid-19, muddying the waters as the World Health Organization prepares to launch a long-awaited investigation into the origins of the pandemic. In recent weeks, Chinese state media, often suggesting the virus came from outside China, have seized on a series of recent studies that show it was spreading outside the country earlier than first assumed. Government officials have also pushed the theory that the virus could have hitched a ride into the central Chinese city of Wuhan on frozen-food imports. After outbreaks in multiple Chinese cities in recent months including Beijing, Shanghai, Tianjin and elsewhere, authorities pointed to frozen-food packaging as the potential origin. https://www.wsj.com/articles/china-pushes-alternative-theori…1607445463


WSJ Membership.

Dec 26, 2020

First two cases of more contagious COVID virus detected in Canada

Posted by in category: biotech/medical

TORONTO (AP) — Officials in Canada’s most populous province have confirmed the first two known Canadian cases of a more contagious variant of COVID-19 that was first identified in the United Kingdom.

The province’s associate chief medical officer says that the cases are a couple from Durham Region, just east of Toronto, with no known travel history, exposure or high-risk contacts.

The new variant is believed to spread more easily and faster than the original version of the disease but is not believed to be more deadly.

Dec 26, 2020

For only $160 billion, you can buy … Mars!

Posted by in categories: biotech/medical, business, health, space travel

NASA scientists and their colleagues are now proposing corporate financing for a human mission to Mars. This raises the prospect that a spaceship named the Microsoft Explorer or the Google Search Engine could one day go down in history as the first spaceship to bring humans to the Red Planet.

The proposal suggests that companies could drum up $160 billion for a human mission to Mars and a colony there, rather than having governments fund such a mission with tax dollars.

Joel Levine, a senior research scientist at NASA Langley Research Center, was quoted in a release in the Journal of Cosmology by Dr. Rhawn Joseph. The plan covers “every aspect of a journey to the Red Planet — the design of the spacecrafts, medical health and psychological issues, the establishment of a Mars base, colonization, and a revolutionary business proposal to overcome the major budgetary obstacles which have prevented the U.S. from sending astronauts to Mars,” said Levine.

Dec 26, 2020

UV-LED disinfection of Coronavirus: Wavelength effect

Posted by in categories: biotech/medical, computing

UV light-emitting diodes (UV LEDs) are an emerging technology and a UV source for pathogen inactivation, however low UV-LED wavelengths are costly and have low fluence rate. Our results suggest that the sensitivity of human Coronavirus (HCoV-OC43 used as SARS-CoV-2 surrogate) was wavelength dependent with 267 nm ~ 279 nm 286 nm 297 nm. Other viruses showed similar results, suggesting UV LED with peak emission at ~286 nm could serve as an effective tool in the fight against human Coronaviruses.

Dec 26, 2020

Stanford scientists assemble human nerve circuit driving voluntary movement

Posted by in categories: biotech/medical, neuroscience

A Stanford Medicine team used human stem cells to assemble a working nerve circuit connecting brain tissue to muscle tissue. The research could enable scientists to better understand neurological disorders that affect movement.

Dec 26, 2020

The Most Common Pain Relief Drug in The World Has Been Linked to Risk-Taking Behaviour

Posted by in category: biotech/medical

One of the most consumed drugs in the US – and the most commonly taken analgesic worldwide – could be doing a lot more than simply taking the edge off your headache, recent evidence suggests.

Acetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, also increases risk-taking, according to a September 2020 study that measured changes in people’s behaviour when under the influence of the common over-the-counter medication.

“Acetaminophen seems to make people feel less negative emotion when they consider risky activities – they just don’t feel as scared,” said neuroscientist Baldwin Way from The Ohio State University in September 2020.

Dec 25, 2020

Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions

Posted by in categories: biotech/medical, health, nanotechnology

Severe allergy-like reactions in at least eight people who received the COVID-19 vaccine produced by Pfizer and BioNTech (and Moderna now) over the past 2 weeks may be due to a compound in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient, scientists say. A similar mRNA vaccine developed by Moderna, which was authorized for emergency use in the United States on Friday, also contains the compound, polyethylene glycol (PEG) PEG has never been used before in an approved vaccine, but it is found in many drugs that have occasionally triggered anaphylaxis—a potentially life-threatening reaction that can cause rashes, a plummeting blood pressure, shortness of breath, and a fast heartbeat. Some allergists and immunologists believe a small number of people previously exposed to PEG may have high levels of antibodies against PEG, putting them at risk of an anaphylactic reaction to the vaccine.


Life-threatening responses seen in at least eight people could be linked to polyethylene glycol, known to trigger reactions to some drugs.

Dec 25, 2020

Media release BWXT make significant progress towards producing life-saving isotope at Darlington

Posted by in categories: biotech/medical, nuclear energy

Peterborough, ON — Ontario Power Generation (OPG), its subsidiary Laurentis Energy Partners (Laurentis), BWXT ITG Canada Inc. and its affiliates (BWXT) are making significant progress toward the production of molybdenum-99 (Mo-99) at OPG’s Darlington Nuclear Generating Station. Mo-99 is a much-needed medical isotope used in over 40 million procedures a year to detect cancers and diagnose various medical conditions.

Over the past 24 months, a team of more than 100 personnel at BWXT and Laurentis designed specialized tooling at BWXT’s facility in Peterborough to enable the production of Mo-99 at Darlington. The manufacturing of this specialized tooling is currently underway at the same BWXT facility in Peterborough.

BWXT has also built a fabrication facility at its current location in Peterborough to produce Mo-99 components that will be delivered by the specialized tooling, which will be installed at Darlington. The tooling will deliver the molybdenum into the Darlington reactor for irradiation, which will enable Darlington to become the first commercial operating nuclear reactor to produce Mo-99.

Continue reading “Media release BWXT make significant progress towards producing life-saving isotope at Darlington” »

Dec 25, 2020

Protein may clarify Alzheimer’s and body clock link

Posted by in categories: biotech/medical, neuroscience

Poor sleep and other issues with circadian rhythm are common for people with Alzheimer’s disease. Now researchers may have a clue to why.


“If your circadian clock is not quite right for years and years—you routinely suffer from disrupted sleep at night and napping during the day—the cumulative effect of chronic dysregulation could influence inflammatory pathways such that you accumulate more amyloid plaques,” says Erik Musiek. (Credit: Getty Images)

Fractured sleep, daytime sleepiness, and other signs of disturbance in one’s circadian rhythm are common complaints of people with Alzheimer’s disease, and the problems only get worse as the disease progresses.

Dec 25, 2020

World’s shortest wavelength for a vertical-cavity surface-emitting laser demonstrated

Posted by in categories: biotech/medical, mobile phones, robotics/AI

Researchers at Chalmers University of Technology, with collaborators at Technische Universität Berlin, have demonstrated the shortest wavelength ever reported of a vertical-cavity surface-emitting laser (VCSEL). This can pave the way for future use in, for example, disinfection and medical treatment. The results were recently published in the scientific journal ACS Photonics.

“Although there is still much work to be done, especially to enable electrically driven devices, this demonstration provides an important building block for the realization of practical VCSELs covering the major part of the UV spectral range,” says Filip Hjort, Ph.D. student at the Photonics Laboratory at mc2 and first author of the article.

A vertical-cavity surface-emitting lasers (VCSEL) is a compact semiconductor laser and has seen widespread application in, for example, facial recognition in smartphones and for optical communication in data centers. So far, these lasers are only available commercially with red and , but also other visible-emitting VCSELs, that could find applications in adaptive headlamps for cars or projection displays, will soon be commercialized.